Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Bleeding in Patients with Atrial Fibrillation Treated with Different Doses of Direct Oral Anticoagulants and Vitamin K Antagonists: A Population-Based Study

Martin H. Ellis, MD, Orly Avnery, MD, Estela Derazne, MSc, Erez Battat, Sari Greenberg Dotan, Ariel Hammerman, John Eikelboom, MD, Jeffrey S. Ginsberg, MD, Jack Hirsh, MD

Blood (2016) 128 (22): 2617.

https://doi.org/10.1182/blood.V128.22.2617.2617

Published: 2016

Journal Articles

Bleeding in Patients with Atrial Fibrillation Treated with Non Vitamin K Antagonist Oral Anticoagulants: A Population-Based Study

Martin H. Ellis, MD, Tsipora Neumann, Jeffrey S Ginsberg, MD, John W Eikelboom, MBBS, MSc, FRACP, FRCPA, Haim Bitterman, Ariel Hammerman, Erez Battat, Sari Greenberg, Jack Hirsh, MD

Blood (2014) 124 (21): 343.

https://doi.org/10.1182/blood.V124.21.343.343

Published: 2014

Journal Articles

Role of phenotypic and genetic testing in managing clopidogrel therapy

Noel C. Chan, John W. Eikelboom, Jeffrey S. Ginsberg, Mandy N. Lauw, Thomas Vanassche, Jeffrey I. Weitz, Jack Hirsh

Blood (2014) 124 (5): 689–699.

https://doi.org/10.1182/blood-2014-01-512723

Published: 2014

Journal Articles

Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model

Petr Klement, Leslie R. Berry, Peng Liao, Henry Wood, Paul Tressel, Lesley J. Smith, Nihal Haque, Jeffery I. Weitz, Jack Hirsh, Nethnapha Paredes, Anthony K.C. Chan

Blood (2010) 116 (25): 5716–5723.

https://doi.org/10.1182/blood-2010-05-284448

Published: 2010

Journal Articles

Evaluation of a VENOus-Return Assist Device ( Venowave ™ ) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial.

Martin O’Donnell, MB, Simon McRae, MD, Susan Kahn, MD MSc, Jim Julian, MMath, Clive Kearon, MB PhD, Betsy MacKinnon, MSc, Debbie Magier, RN, Carla Strulovitch, RN, Theresa Lyons, RN, Jack Hirsh, MD, Jeffrey Ginsberg, MD

Blood (2006) 108 (11): 877.

https://doi.org/10.1182/blood.V108.11.877.877

Published: 2006

Journal Articles

New anticoagulants

Jack Hirsh, Martin O'Donnell, Jeffrey I. Weitz

Blood (2005) 105 (2): 453–463.

https://doi.org/10.1182/blood-2003-12-4195

Published: 2005

Journal Articles

Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring for Acute Treatment of Venous Thromboembolism (VTE): Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH).

Clive Kearon, MD, Jeffrey J. Ginsberg, MD, Jim Julian, James Douketis, MD, Susan Solymoss, MD, Paul Ockelford, MD, Sharon Jackson, MD, Graham Turpie, MD, Donna McCarty, Betsy MacKinnon, Jack Hirsh, MD, Michael Gent, (for the FIDO Investigators)

Blood (2004) 104 (11): 707.

https://doi.org/10.1182/blood.V104.11.707.707

Published: 2004

Journal Articles

Incidence of Recurrent Venous Thromboembolism According to Duration of Vitamin K Antagonists: Results of a Meta-Analysis on Individual Data.

Florent Boutitie, PhD, Laurent Pinede, MD, Sam Schulman, MD, Giancarlo Agnelli, MD, Gary Rascob, MD, Jim Jullian, MD, Jack Hirsh, MD, Clive Kearon, MD

Blood (2004) 104 (11): 710.

https://doi.org/10.1182/blood.V104.11.710.710

Published: 2004

Journal Articles

How we diagnose and treat deep vein thrombosis

Jack Hirsh, Agnes Y. Y. Lee

Blood (2002) 99 (9): 3102–3110.

https://doi.org/10.1182/blood.V99.9.3102

Published: 2002

Journal Articles

A Histomorphometric Evaluation of Heparin-Induced Bone Loss After Discontinuation of Heparin Treatment in Rats

Stephen G. Shaughnessy, Jack Hirsh, Mohit Bhandari, Jeffrey M. Muir, Edward Young, Jeffrey I. Weitz

Blood (1999) 93 (4): 1231–1236.

https://doi.org/10.1182/blood.V93.4.1231

Published: 1999

Journal Articles

A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats

Jeffrey M. Muir, Jack Hirsh, Jeffrey I. Weitz, Maureen Andrew, Edward Young, Stephen G. Shaughnessy

Blood (1997) 89 (9): 3236–3242.

https://doi.org/10.1182/blood.V89.9.3236

Published: 1997

Journal Articles

Effect of Streptokinase on Hemostasis

JACK HIRSH, M.D., MRACP, MICHAEL BUCHANAN, MICHAEL F. GLYNN, M.D., FRCP (C), JAMES F. MUSTARD, M.D., PH.D., FRCP (C)

Blood (1968) 32 (5): 726–737.

https://doi.org/10.1182/blood.V32.5.726.726

Published: 1968

NARROW

Bleeding in Patients with Atrial Fibrillation Treated with Different Doses of Direct Oral Anticoagulants and Vitamin K Antagonists: A Population-Based Study

Bleeding in Patients with Atrial Fibrillation Treated with Non Vitamin K Antagonist Oral Anticoagulants: A Population-Based Study

Role of phenotypic and genetic testing in managing clopidogrel therapy

Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model

Evaluation of a VENOus-Return Assist Device ( Venowave ™ ) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial.

New anticoagulants

Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring for Acute Treatment of Venous Thromboembolism (VTE): Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH).

Incidence of Recurrent Venous Thromboembolism According to Duration of Vitamin K Antagonists: Results of a Meta-Analysis on Individual Data.

How we diagnose and treat deep vein thrombosis

A Histomorphometric Evaluation of Heparin-Induced Bone Loss After Discontinuation of Heparin Treatment in Rats

A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats

Effect of Streptokinase on Hemostasis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only